One-month treatment for latent tuberculosis. Why aren't we using it? (Hint: We should.) voices.nejm.org/doi/full/10....

One-Month Treatment for Latent Tuberculosis

Why aren’t we using it?

voices.nejm.org

On IDSA’s & HIVMA’s Science Speaks blog: A study in CID looked at clinical features and predictors of mortality for Legionella pneumonia across a large integrated health system. Read IDSA’s Journal Club review by Christopher J. Graber, MD, MPH, FIDSA: https://bit.ly/3NOpG4M

Troubled waters: Legionella pneumonia in the modern era

A study in CID looked at clinical features and predictors of mortality for Legionella pneumonia. Read IDSA's Journal Club review by Christopher J. Graber, MD, MPH, FIDSA.

bit.ly

Should ID provide primary care to patients with HIV? Point and counter point in @cidjournal.bsky.social Work with primary care for PLWH: doi.org/10.1093/cid/... Work as primary care for PLWH: doi.org/10.1093/cid/... #IDSky

Providing the Best Infectious Diseases and Primary Care to Our Patients With HIV: Time for Delivery Models to Evolve

Advances in care for patients with human immunodeficiency virus have simplified the management of infectious disease–related conditions, yet primary care h

doi.org

Would love to spark a discussion with our recent point-counterpoint in CID on the future of ID-HIV primary care. My colleagues and I argue that we AND our patients are better off leaving the intricacies of primary care to those who do it more than we do. academic.oup.com/cid/advance-...

Providing the Best Infectious Diseases and Primary Care to Our Patients With HIV: Time for Delivery Models to Evolve

Advances in care for patients with human immunodeficiency virus have simplified the management of infectious disease–related conditions, yet primary care h

academic.oup.com

what I like about Roon so far: 1. More back-and-forth discussion 2. Ability to follow certain topics in “spaces” (e.g., AI in medicine, health policy, med ed, medical reasoning) 3. You can’t tell how many followers you have (less clout-chasing and virtue signaling) 4. No bots or trolls

Remember the glory days of #IDTwitter? Want to have discussions with your colleagues without sifting through the slop of X and the echo chambers of Bluesky? Come join what we are building over at Roon!

Bruin. Doin’ us proud.

NBC News@nbcnews.com · 6mo ago

BREAKING: Alysa Liu wins the gold medal in women's figure skating.

Are you an ID pharmacist currently in the VA system who wants to live in an awesome city and work with awesome people? Look no further. www.usajobs.gov/job/858066800

USAJOBS connects job seekers with federal jobs across the United States and around the world as the official employment site for the federal government

The Clinical Pharmacist Specialist for Infectious Diseases must be a licensed pharmacist, have expert knowledge of infectious disease/antimicrobial medication therapy and management, and have an exper...

usajobs.gov

My latest for IDSA Journal Club: a review of a recent CID paper that finds similar outcomes in CAP patients with pos viral testing when treated with 0-2d vs 5-7d abx, adding fuel to recent IDSA-ATS controversy. www.idsociety.org/science-spea...

Antibiotics in community-acquired pneumonia when respiratory viruses are detected: Adding more fuel to the fire?

A study in CID examined associations between antibiotic use and outcomes in patients hospitalized with community-acquired pneumonia and positive respiratory viral assays.

idsociety.org

just referred to a smoldering leukocytosis as “low-key” on rounds today…not sure if I’m chopped, cringe, or goated

I did not have @mmpharmd.bsky.social making a 6-7 reference in a CID article on my bingo card of things that were going to make my day today but here we are academic.oup.com/cid/advance-...

did ABIM really just send me my LKA Wrapped?

we’re talkin’ CloCeBa at @idsainfo.bsky.social Journal Club this month! Do we need to think about adding blaZ type to rapid diagnostic panels for MSSA bacteremia? www.idsociety.org/science-spea...

Anti-staphylococcal penicillins versus cefazolin for methicillin-susceptible S. aureus bacteremia: Is there a role for determining blaZ type?

A study in The Lancet addressed cloxacillin versus cefazolin for methicillin-susceptible S. aureus bacteremia. Read IDSA’s Journal Club review by Christopher J. Graber.

idsociety.org

The 6 “coms” of why we are losing the battle over public health: complacency, commitment, commercialism, complexity, communication, and comportment www.nejm.org/doi/full/10....

Restoring Confidence in Public Health | NEJM

A confluence of interrelated factors has put past progress in public health at serious risk in the United States. How did we get here, and what can public health professionals do about it?

nejm.org

With UW’s Dr Paul Pottinger and others, new discussion re: fostering ID advocacy in ID fellowship. They note: Policies with a negative impact on ID clinical care, public health, & research underscore the importance of mobilizing the field of ID to advocacy academic.oup.com/ofid/advance... #IDSky

Amplifying Our Voices: Fostering Advocacy in Infectious Diseases Fellowship

This white paper, devised from the Infectious Diseases Society of America's National Training Program Director annual meeting, outlines practical strategie

academic.oup.com

beginning to realize the stages of @idweek.bsky.social attendance according to career stage: 1. The Learner: the student/resident/fellow that goes to learn and absorb.

Feeling inspired seeing so many enthusiastic trainees at #IDWeek2025! We have a 2026-27 opening for our 1-year Transplant ID Advanced Training Program at #UCLA, pls reach out with any questions #IDfellow #TxID @idweek.bsky.social #IDSky @ucla-id-fellowship.bsky.social recruit.apo.ucla.edu/JPF10380

Transplant Infectious Diseases Career Development Position 2026-2027

University of California, Los Angeles is hiring. Apply now!

recruit.apo.ucla.edu

Well done to all the teams! Time for everyone to start making plans for BugBowl 2026 in DC!

IDWeek@idweek.bsky.social · 10mo ago

This year’s #IDBugBowl was a HIT! 🐛🏆 Congratulations to our winners from the University of Alabama at Birmingham and all of our participants from the Cleveland Clinic Foundation, Thomas Jefferson University Hospital, and the Calcutta School of Tropical Medicine!

Get psyched! Come for the ATL-themed puns, stay for the knowledge!

DocWoc71@docwoc71.bsky.social · 10mo ago

Getting ready for #IDBugBowl @idweek.bsky.social Hope to see y’alll this afternoon. Come and cheer ur team UAB CCF ThomasJefferson and our international team Calcutta Troo Med #IDWeek2025 #IDSky

On IDSA’s & HIVMA’s Science Speaks blog: Christopher J. Graber, MD, MPH, FIDSA, explores dalbavancin versus standard therapy for completion of treatment of complicated S. aureus bacteremia. https://bit.ly/4ncqnAt

DOT-ting i's and crossing t's: More evidence for using long-acting glycopeptides to finish therapy of complicated S. aureus bacteremia

A JAMA study looked at dalbavancin versus standard therapy for completion of treatment of complicated S. aureus bacteremia. Read IDSA's Journal Club review.

idsociety.org

Looking to do some stewardship and/or hospital epi? Join me, @wbranchelliman.bsky.social, and our crew at VA Greater Los Angeles!

best admin assistant (and pre-interview Zoom DJ) ever!

UCLA Department of Medicine@domucla.bsky.social · 11mo ago

Meet Claire Echeverri, administrative assistant in the division of infectious diseases. From managing schedules to supporting fellows and faculty, her adaptability and professionalism keep the division running smoothly. Learn more about Claire here: uclahs.fyi/4m9qGLT

Colleagues- in case this was missed during summer vacation, please share. I just went to the Bowl again last week and saw Yo-Yo Ma and Angelique Kidjo. The Bowl is not the only reason to be in LA....but it is pretty spectacular. Also my ASP team is just the bee's knees.

Tara Vijayan@nottheogdrv.bsky.social · last yr.

Please consider joining our incredible faculty and ASP program at UCLA Health. Los Angeles is an incredible city and always will be. recruit.apo.ucla.edu/JPF10331

the marker of a good journal club is that the fellows have already left for clinic and the attendings are still arguing

I demand a randomized controlled trial of hiring people who resign back to their prior jobs. The public deserves nothing less.

Helen Branswell 🇨🇦@helenbranswell.bsky.social · last yr.

Big news: Vinay Prasad is returning to #FDA as head of the center for biologics, @lizzylawrence.bsky.social reports. www.statnews.com/2025/08/09/v...

Moderate immunocompromise (even if overly broadly defined) should not buy you vanc + antipseudomonal for CAP: my latest @idsainfo.bsky.social Journal Club review: www.idsociety.org/science-spea...

Broad-spectrum antibiotics for moderately immunocompromised patients with CAP: An overdone practice

A study in CID examined broad-spectrum antibiotics in moderately immunocompromised patients with community-acquired pneumonia

idsociety.org

my fellow just put up a slide in case conference with the “distracted boyfriend” meme for linezolid overtaking clindamycin as the “toxin” drug of choice and never have I been more proud as a program director

let’s goooooooooooooo

IDWeek@idweek.bsky.social · last yr.

Coming soon to an IDWeek near you... 👀 Register today for #IDWeek2025 before rates increase this Saturday, Aug. 2: idweek.org/registration

we’ve all been there, right?

most men aren’t complicated, it turns out (at least as it pertains to UTI)

IDSA@idsainfo.bsky.social · last yr.

🚨 IDSA has released the first guidelines for the management and treatment of complicated urinary tract infections (cUTIs)! The new guidelines simplify the prior definitions of uncomplicated UTIs and cUTIs, & address treatment for cUTIs. View guidelines: bit.ly/4lUjN1a